Posted on 11/7/17
Biogen (BIIB) Report 24 -Month Interim Analysis from PRIME
The following slide deck was published by Biogen Inc. in conjunction with this event. 120READ FULL ARTICLE HERE
Posted on 11/7/17
Keryx Biopharmaceuticals, Inc. Fell 8.6% In October -- Here's Why That Doesn't Matter
What happenedShares of Keryx Biopharmaceuticals (NASDAQ:KERX), a commercial-stage biopharma focused on kidney disease, fell 8.6% in October according to data from S&P Global Market Intelligence. However, . . .
Posted on 11/7/17
Voyager Therapeutics Announces Proposed Offering of Common Stock
CAMBRIDGE, Mass., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, . . .
Posted on 11/7/17
Spero Therapeutics Closes IPO
CAMBRIDGE, Mass., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc., a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug . . .
Posted on 11/7/17
Tufts Medical Center and MORE Health Announce Strategic Alliance
BOSTON & FOSTER CITY, Calif.--(BUSINESS WIRE)--Tufts Medical Center and MORE Health, a Silicon Valley-based global healthcare IT company, today announced a strategic alliance that gives patients . . .
Posted on 11/7/17
The Medicines Company and Alnylam Pharmaceuticals Announce Initiation of Phase III Clinical Trials of Inclisiran
PARSIPPANY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Medicines Company (NASDAQ: MDCO) and Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) today announced the initiation of the Phase III clinical program . . .
Posted on 12/18/17
Concert Pharmaceuticals Announces Completion of Enrollment in First Cohort of CTP-543 Phase 2a Trial
LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has completed enrollment of the first cohort of its Phase 2a trial evaluating CTP-543. . . .
Posted on 11/6/17
The Cost Benefit of Health Care Transparency
As our nation seeks solutions to help improve the healthcare system, there is at least one goal we can all agree on: the importance of making . . .
Posted on 11/6/17
5 Tips To Help Americans Prepare For Open Enrollment And Save On Healthcare Costs
More than 70 percent of Americans say they are prepared for open enrollment, yet most people struggle to understand basic health insurance terms, according to a . . .
Posted on 11/6/17
Check-Cap Reports Third Quarter 2017 Financial Results
Check-Cap Ltd. (NASDAQ: CHEK; CHEKW), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, today announced its . . .
Posted on 11/6/17
CVS Health Reports Third Quarter Results
Third Quarter Year-over-year Highlights: Net revenues increased 3.5% to $46.2 billionGAAP diluted EPS from continuing operations of $1.26Adjusted EPS of $1.50Year-to-date Highlights: Generated cash flow from . . .
Posted on 11/6/17
Kala Pharmaceuticals: Taking A Look At This Summer IPO
Shares of Kala Pharmaceuticals (KALA) fell to the mid-$13 range prior to Friday's rebound back above $15 on decent volume.KALA data by YChartsThe company was not . . .
Posted on 11/6/17
Vedanta Biosciences Awarded Up To $5.4 Million from CARB-X
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, an affiliate of PureTech Health (LSE: PRTC), pioneering a novel category of therapies designed to modulate pathways of interaction between the human . . .
Posted on 11/6/17
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, announced that, on November 1, . . .
Posted on 11/6/17
Dartmouth-Hitchcock Health Expands Relationship with Conifer Health
FRISCO, Texas--(BUSINESS WIRE)--Conifer Health Solutions today announced an agreement to provide comprehensive revenue cycle management (RCM) services for Cheshire Medical Center, a 116-bed, rural hospital affiliate . . .
Posted on 11/6/17
Akebia Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), . . .
Posted on 11/6/17
Eleven Biotherapeutics Closes $8.0 Million Underwritten Public Offering
CAMBRIDGE, Mass--(BUSINESS WIRE)--Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical oncology company advancing novel product candidates based on its Targeted Protein Therapeutics (TPTs) platform, today announced the . . .
Posted on 11/3/17
Ironwood Pharmaceuticals, Inc. 2017 Q3 - Results - Earnings Call Slides
The following slide deck was published by Ironwood Pharmaceuticals, Inc. in conjunction with their 2017 Q3 earnings call. 121READ FULL ARTICLE HERE
Posted on 11/3/17
Xenetic Biosciences Enters Into Sublicense Agreement Related to its PolyXen Technology with Baxalta
LEXINGTON, Mass.--(BUSINESS WIRE)--Xenetic Biosciences, Inc. (NASDAQ: XBIO), a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel orphan oncology . . .
Posted on 11/3/17
Maryland Hospitals Reach HIMSS Stage 7 with MEDITECH's Clinically-Integrated EHR
Frederick Memorial Hospital (FMH) and Union Hospital of Cecil County (UHCC) are the first MEDITECH customers in Maryland to reach Stage 7 on the HIMSS Electronic . . .
Posted on 11/2/17
Peak Physical Therapy & Sports Performance Hosts Ribbon-cutting Ceremony
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive treatment in orthopedic, spine and sports medicine specialties, recently . . .
Posted on 11/2/17
Symbiotix Biotherapies Receives $5 Million in Institutional Financing
BOSTON--(BUSINESS WIRE)--Symbiotix Biotherapies, Inc., a pioneering microbiome company developing novel molecular therapeutics based on the human microbiome, today announced the completion of $5 million in institutional . . .
Posted on 11/2/17
Eleven Biotherapeutics Prices of $8.0 Million Underwritten Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical oncology company advancing novel product candidates based on its Targeted Protein Therapeutics (TPTs) platform, today announced the . . .
Posted on 11/2/17
CVS Health Foundation Awards $1 Million Dollars in Grants to Eight Cancer Centers
The CVS Health Foundation today announced it has awarded $1 million dollars in grants to eight Association of American Cancer Institutes (AACI) member cancer centers to . . .
Posted on 12/1/17
Boston-Based Medical Device Start-Up Launches U Boost
Ms. (Motherhood/Sisterhood) United, a medical device start-up focused on developing novel breast pumping technology, today announced the launch of its Kickstarter campaign for U Boost, a . . .
Boston
